Global Pet Cancer Therapeutics Market projected to reach USD 1,162.4 Million by 2033, growing at 9.2% CAGR.

From GlobeNewswire: 2024-04-08 13:30:00

The global Pet Cancer Therapeutics Market is projected to reach USD 1,162.4 Million by 2033, growing at a CAGR of 9.2%. Factors driving this growth include increasing pet ownership trends, advancements in veterinary medicine, rising pet cancer incidence, and growing awareness. Expansion of veterinary oncology services and investments in research are also contributing to market growth.

In 2023, the Canine Tumor Genome Atlas was launched, focusing on comparative oncology in companion dogs with oral melanomas, osteosarcomas, and gliomas. Petco Love allocated USD 15 million in grants to support shelter operations and promote pet adoption efforts in the United States. These initiatives aim to advance research and improve cancer treatment for pets.

The COVID-19 pandemic has impacted the Pet Cancer Therapeutics Market, leading to disruptions in veterinary services, financial constraints for pet owners, and changes in demand for cancer treatments. However, the resumption of veterinary services, rise in pet adoption, expansion of telemedicine, and focus on research and innovation are supporting the market’s recovery.

Key questions addressed in the report include the size and growth rate of the Pet Cancer Therapeutics market, primary driving factors, top companies, market segments, fastest-growing regions, role of essential players in the value chain, and how to obtain a free sample report. Market Share, size, forecast by revenue, and other key offerings are included in the report for comprehensive insights into the Pet Cancer Therapeutics Market.



Read more at GlobeNewswire: [Latest] Global Pet Cancer Therapeutics Market Size/Share